The 41-gene classifier TRAR predicts response of HER2 positive breast cancer patients in the NeoSphere study. (April 2018) - Triulzi, T.; Di Cosimo, S.; Bianchini, G.; Pienkowski, T.; Im, Y.H.; Bianchi, G.V.; De Cecco, L.; Tseng, L.M.; Liu, M.C.; Lluch, A.; Semiglazov, V.; De la Haba-Rodriguez, J.; et al.